R
Rafael de Cabo
Researcher at National Institutes of Health
Publications - 354
Citations - 41807
Rafael de Cabo is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Calorie restriction & Medicine. The author has an hindex of 91, co-authored 317 publications receiving 35020 citations. Previous affiliations of Rafael de Cabo include University of Córdoba (Spain) & University of Oklahoma Health Sciences Center.
Papers
More filters
Journal ArticleDOI
Resveratrol improves health and survival of mice on a high-calorie diet
Joseph A. Baur,Kevin J. Pearson,Nathaniel O Price,Hamish A. Jamieson,Carles Lerin,Avash Kalra,Vinayakumar Prabhu,Joanne S. Allard,Guillermo López-Lluch,Kaitlyn N. Lewis,Paul J. Pistell,Suresh Poosala,Kevin G. Becker,Olivier Boss,Dana M. Gwinn,Mingyi Wang,Sharan Ramaswamy,Kenneth W. Fishbein,Richard G. Spencer,Edward G. Lakatta,David G. Le Couteur,Reuben J. Shaw,Plácido Navas,Pere Puigserver,Donald K. Ingram,Rafael de Cabo,David A. Sinclair +26 more
TL;DR: It is shown that resveratrol shifts the physiology of middle-aged mice on a high-calorie diet towards that of mice onA standard diet and significantly increases their survival and point to new approaches for treating obesity-related disorders and diseases of ageing.
Journal ArticleDOI
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase.
Haim Y. Cohen,Christine M. Miller,Kevin J. Bitterman,Nathan R. Wall,Brian G Hekking,Benedikt M. Kessler,Konrad T. Howitz,Myriam Gorospe,Rafael de Cabo,David A. Sinclair +9 more
TL;DR: It is shown that expression of mammalian Sir2 (SIRT1) is induced in CR rats as well as in human cells that are treated with serum from these animals, suggesting that CR could extend life-span by inducing SIRT1 expression and promoting the long-term survival of irreplaceable cells.
Journal ArticleDOI
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
Nathan L. Price,Ana P. Gomes,Alvin J. Y. Ling,Filipe V. Duarte,Alejandro Martin-Montalvo,Brian J. North,Beamon Agarwal,Lan Ye,Giorgio Ramadori,João S. Teodoro,Basil P. Hubbard,Ana T. Varela,James G. Davis,Behzad Varamini,Angela Hafner,Ruin Moaddel,Anabela P. Rolo,Roberto Coppari,Roberto Coppari,Carlos M. Palmeira,Rafael de Cabo,Joseph A. Baur,David A. Sinclair,David A. Sinclair +23 more
TL;DR: Mice treated with a moderate dose of resveratrol showed increased mitochondrial biogenesis and function, AMPK activation, and increased NAD(+) levels in skeletal muscle, whereas SIRT1 knockouts displayed none of these benefits, whereas a mouse overexpressing Sirt1 mimicked these effects.
Journal ArticleDOI
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Tadahiro Shimazu,Matthew D. Hirschey,John C. Newman,Wenjuan He,Kotaro Shirakawa,Natacha Le Moan,Carrie A. Grueter,Hyung W. Lim,Laura Saunders,Robert Stevens,Christopher B. Newgard,Robert V. Farese,Rafael de Cabo,Scott M. Ulrich,Katerina Akassoglou,Eric Verdin +15 more
TL;DR: It is reported that the ketone body d-β-hydroxybutyrate (βOHB) is an endogenous and specific inhibitor of class I histone deacetylases (HDACs), and treatment of mice with βOHB conferred substantial protection against oxidative stress.
Journal ArticleDOI
Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span.
Kevin J. Pearson,Joseph A. Baur,Kaitlyn N. Lewis,Leonid Peshkin,Nathan L. Price,Nathan L. Price,Nazar Labinskyy,William R. Swindell,Davida Kamara,Robin K. Minor,Evelyn Perez,Hamish A. Jamieson,Yongqing Zhang,Stephen R. Dunn,Kumar Sharma,Nancy Pleshko,Laura A. Woollett,Anna Csiszar,Yuji Ikeno,David G. Le Couteur,Peter J. Elliott,Kevin G. Becker,Plácido Navas,Donald K. Ingram,Norman S. Wolf,Zoltan Ungvari,David A. Sinclair,Rafael de Cabo +27 more
TL;DR: It is found that resveratrol treatment has a range of beneficial effects in mice but does not increase the longevity of ad libitum-fed animals when started midlife.